Relmada Therapeutics Inc.

NASDAQ: RLMD · Real-Time Price · USD
0.60
-0.06 (-9.64%)
At close: Aug 19, 2025, 3:57 PM
0.59
-1.80%
After-hours: Aug 19, 2025, 06:04 PM EDT

Relmada Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-67.81M -75.71M -79.98M -86.49M -86.76M -94.3M -98.79M -111.57M -128.99M -143.62M -157.04M -153.48M -156.67M -143.28M -125.75M -112.14M -86.43M -71M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 452.00 1.26K 2.08K 2.94K 3.51K
Stock-Based Compensation
22.59M 26.36M 30.18M 33.35M 36.8M 40.75M 43.81M 45.54M 42.49M 43.62M 44.19M 50.93M 50.6M 46.57M 40.49M 25.32M 22.56M 21.59M
Other Working Capital
3.01M 1.45M 2.27M 5.94M 2.43M 3.83M 4.84M -4.7M -5.22M 2.97M 10.17M 4.69M 5.8M -3.89M -10.71M 2.49M 867.75K 2.82M
Other Non-Cash Items
-4.92M -4.97M -4.86M -5.5M 34.43K 761.71K 241.16K -5.35M 1.88M -3.95M -1.55M -5.44M -2.81M 2.8M 1.25M 11.2M 788K -859.63K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
206.53K -2.46M 2.9M 5.43M 1.75M 4.59M 3.08M -5.92M -7.91M 3.07M 10.59M 2.41M 9.24M -1.31M -7.86M 14.47M 10.36M 9.8M
Operating Cash Flow
-49.92M -56.79M -51.76M -53.21M -48.18M -48.19M -51.66M -77.29M -92.52M -100.88M -103.8M -105.58M -99.63M -95.22M -91.87M -61.14M -52.73M -40.47M
Capital Expenditures
3.00 12.00 9.00 9.00 9.00 4.00 4.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-4.58M -5.55M -12.08M -44.74M -53.2M -62.71M -90.46M -65.45M -59.46M -56.15M -47.29M -179.5M -199.52M -228.23M -222.98M -175.76M -176.56M -165.48M
Sales Maturities Of Investments
54.1M 62.42M 63.64M 92.69M 88.87M 83.22M 140.92M 106.51M 128.21M 125.91M 67.03M 109.7M 125.68M 148.62M 168.86M 213.76M 191.64M 170.13M
Other Investing Acitivies
n/a n/a n/a n/a n/a -1.15K 38.85K 37.2K 68.75K 69.76K 19.73K -69.79K -73.84K -79.61K -54.12K 38K 15.08K 4.65K
Investing Cash Flow
49.53M 56.86M 51.56M 47.96M 35.67M 20.51M 50.45M 41.06M 68.75M 69.76M 19.73M -69.79M -73.84M -79.61M -54.12M 38M 15.08M 4.65M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-335.11K -262.09K -287.09K -213.06K -123.46K -123.46K -98.46K 409.88K 275.25K 1.22M 1.59M 1.69M 2M 1.53M 2.63M 2.99M 4.38M 6.47M
Financial Cash Flow
-335.11K -262.09K -40.34K 33.68K 123.28K 123.28K -98.46K 409.88K 978.98K 15.07M 45.02M 206.45M 206.06M 215.96M 187.94M 27.05M 28.5M 27.4M
Net Cash Flow
-732.91K -185.31K -234.54K -5.21M -12.38M -27.56M -1.3M -35.83M -22.79M -16.04M -39.05M 31.08M 32.59M 41.13M 41.95M 3.9M -9.15M -8.42M
Free Cash Flow
-49.92M -56.79M -51.76M -53.21M -48.18M -48.19M -51.66M -77.29M -92.52M -100.88M -103.8M -105.58M -99.63M -95.22M -91.87M -61.14M -52.73M -40.47M